2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cancer genetics<br />
P04.012<br />
A novel PtEN mutation in an italian family with hyperplastic<br />
polyposis <strong>of</strong> the colon in the context <strong>of</strong> cowden syndrome<br />
D. Turchetti 1,2 , L. M. Pradella 1 , C. Rossi 1 , A. Alberani 3 , F. Ferrara 3 , P. A. Fanti 4 ,<br />
G. Romeo 1 ;<br />
1 UO e Cattedra di Genetica Medica - Azienda Ospedaliero-Universitaria Policlinico<br />
S.Orsola-Malpighi, Bologna, Italy, 2 Dipartimento di Oncologia - Presidio<br />
Ospedaliero Bellaria-Maggiore, Bologna, Italy, 3 UO Gastroenterologia ed Endoscopia<br />
Digestiva - Presidio Ospedaliero Bellaria-Maggiore, Bologna, Italy, 4 UO<br />
Dermatologia - Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br />
Clinical manifestations <strong>of</strong> Cowden Syndrome, which is caused by mutations<br />
in the PTEN gene, are extremely variable . Among gastrointestinal<br />
manifestations, hamartomatous polyps are the typical lesions, but<br />
other polyp types, including hyperplastic, have been reported .<br />
We describe a family in which hyperplastic polyposis was the reason<br />
for referral to the genetic clinic and that was found to carry a novel<br />
PTEN mutation .<br />
The proband, a 46 year-old man, was referred to the cancer genetic<br />
clinic because <strong>of</strong> the endoscopic finding <strong>of</strong> colonic polyposis. Histology<br />
showed the polyps to be hyperplastic . Moreover, upper gastrointestinal<br />
endoscopy detected esophageal acanthosis and papillomatosis and<br />
HP-related gastritis . Physical examination revealed the presence <strong>of</strong><br />
macrocephaly (65cm), obesity and cutaneous papillomas . The mother,<br />
62 year-old, had also been diagnosed with hyperplastic polyposis and<br />
with carcinoma ex-adenoma <strong>of</strong> the left colon, for which had undergone<br />
hemicolectomy at age 61 . Previously, she had had hysterectomy for<br />
uterine fibroids at age 47 and mastectomy for invasive ductal carcinoma<br />
<strong>of</strong> the breast at age 51 . Physical examination showed macrocephaly<br />
(59cm), obesity, cutaneous papillomas and subcutaneous<br />
lipomas .<br />
PTEN mutational analysis in the proband revealed the germline heterozygous<br />
mutation 303delA in the exon 5, which was confirmed in the<br />
mother . This mutation, which to our knowledge has never been described<br />
before, generates a stop at codon 111, producing a truncated<br />
protein which looses three functionally relevant domains .<br />
To help clarify the pathogenic mechanism <strong>of</strong> the mutation, we are now<br />
performing molecular studies on pathologic tissues removed from the<br />
patients .<br />
P04.013<br />
Dysregulation <strong>of</strong> RAs signaling in colorectal carcinomas<br />
I. Bottillo 1 , I. Torrente 1 , T. Ahlquist 2 , S. A. Danielsen 2 , G. I. Meling 3 , R. A.<br />
Lothe 2 , B. Dallapiccola 1,4 ;<br />
1 CSS-Mendel Institute, Rome, Italy, 2 Department <strong>of</strong> Cancer Prevention, Institute<br />
for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Oslo,<br />
Norway, 3 Surgical Department, Faculty Division Akershus University Hospital,<br />
University <strong>of</strong> Oslo, Oslo, Norway, 4 Department <strong>of</strong> Experimental Medicine, Sapienza<br />
University, Rome, Italy.<br />
Half <strong>of</strong> all colorectal carcinomas (CRC) have dysregulation <strong>of</strong> the RAS<br />
signaling, increasing the cellular proliferative potential and resistance<br />
to apoptosis . KRAS is known to be commonly mutated in CRC, while<br />
mutational status <strong>of</strong> the NF1 gene, acting as a negative regulator <strong>of</strong><br />
RAS signaling, is not known . We analyzed a series <strong>of</strong> CRC for mutations<br />
in KRAS, BRAF, and NF1 . NF1 coding region screening was<br />
performed by dHPLC (denaturing high performance liquid chromatography),<br />
sequencing and MLPA (multiple ligation-dependent probe<br />
amplification). KRAS and BRAF were analyzed by sequencing . 40%<br />
(26/65) <strong>of</strong> the samples carried a mutation in KRAS, 22% (14/64) in<br />
BRAF, and 13% (3/24) in NF1 . We found that 62% (40/65) <strong>of</strong> the samples<br />
had alterations in one or more <strong>of</strong> the components, meaning they<br />
have a dysregulation <strong>of</strong> the RAS pathway . BRAF and KRAS mutations<br />
were mutually exclusive . BRAF mutation was strongly associated with<br />
microsatellite instability (MSI), female gender, and proximal location .<br />
Among the 24 samples analyzed for mutations in NF1, we found 2<br />
missense and 2 splicing mutations . All NF1 mutations occurred in MSI,<br />
proximal, and female-derived tumors with BRAF mutation . In addition,<br />
we found that 3 <strong>of</strong> the samples had duplication <strong>of</strong> parts or the whole<br />
NF1 gene . In conclusion RAS pathway is dysregulated by mutually<br />
exclusive mutations <strong>of</strong> KRAS and BRAF in the majority <strong>of</strong> CRC . We<br />
show that the activity <strong>of</strong> RAS signaling is likely to be enhanced in more<br />
than 10% <strong>of</strong> the tumors since they harbor mutations in both BRAF and<br />
NF1 .<br />
P04.014<br />
Age related differences in molecular pr<strong>of</strong>iles <strong>of</strong> colorectal<br />
cancers in patients from the Republic <strong>of</strong> macedonia<br />
M. Hiljadnikova - Bajro 1 , T. Josifovski 2 , A. Kapedanovska 1 , Z. Serafimoska 1 ,<br />
Z. Sterjev 1 , N. Matevska 1 , M. Panovski 2 , N. Petrusevska 2 , L. Suturkova 1 , A. J.<br />
Dimovski 1 ;<br />
1 Faculty <strong>of</strong> Pharmacy, Skopje, The former Yugoslav Republic <strong>of</strong> Macedonia,<br />
2 Faculty <strong>of</strong> Medicine, Skopje, The former Yugoslav Republic <strong>of</strong> Macedonia.<br />
Colorectal cancer (CRC) is considered a disease <strong>of</strong> elderly, though<br />
2-3% occurs in patients G (p .H1047R) in 3 cases . We also found c .3073 A>G<br />
(p .T1025A) and c .3145 G>C (p .G1049R) . In one case we found a mutation<br />
which, to our knowledge, has not been reported previously: c .<br />
3074 C>T (p .T1025I) .<br />
Two <strong>of</strong> the patients with exon 20 PIK3CA mutations had metastatic disease<br />
(33%), while 3 <strong>of</strong> 54 (5 .5%) patients with no mutations had metastasis<br />
(p=0 .07) . The mean age at diagnosis for patients with PIK3CA<br />
mutation was 62 .8, and for patients without a mutation - 63 .3 .<br />
Somatic mutations in exon 20 <strong>of</strong> PIK3CA have been shown to be oncogenic<br />
as they lead to an increased PI3K activity . The PI3K regulate<br />
signaling pathways such as cell proliferation, survival and adhesion .<br />
Our results confirm that PIK3CA alterations may play an important role